Document is current

Any future updates will be listed below

<scp>CRISPR</scp> /Cas‐mediated genome editing to treat <scp>EGFR</scp> ‐mutant lung cancer: a personalized molecular surgical therapy

Crossref DOI link: https://doi.org/10.15252/emmm.201506006

Published Online: 2016-01-08

Published Print: 2016-02

Update policy: https://doi.org/10.1002/crossmark_policy

About CrossMark